Ally Bridge Group »

Assembly Biosciences shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Assembly Biosciences (ASMB) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Assembly Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Assembly Biosciences held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Assembly Biosciences by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 140k 27.48

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding Assembly Biosciences

Gilead Sciences
Farallon Capital Management
RA Capital Management
Commodore Capital
Jupiter Topco
Henderson Group
Paradigm Biocapital Advisors
Vanguard Capital Management
Point72 Asset Management
Parkman Healthcare Partners
Millennium Management
Geode Capital Management
Schonfeld Strategic Advisors
Standard Life Aberdeen
BlackRock

View all funds holding Assembly Biosciences